To evaluate a possible in¯uence of a hereditary trait for obesity on the regulation of adipocyte metabolism in vitro in subcutaneous fat cells in obese and non-obese subjects. DESIGN: A biopsy from abdominal subcutaneous fat was obtained from consecutive subjects with or without a family trait for obesity. A positive family history of obesity was considered present if one or more of the ®rst degree relatives had a BMI of 27 kgam 2 or more. SUBJECTS: 67 non-obese and 60 obese subjects, age 19 ± 60 y. A family trait for overweight was present in 42 of the lean subjects and in 50 of the obese subjects. MEASUREMENTS: Fat cells were isolated and incubated in vitro with isoprenaline (a non-selective beta-adrenoceptor agonist), forskolin (activates the adenylyl cyclase) and dibutyryl cyclic AMP (stimulates the protein kinase hormonesensitive lipase complex). Glycerol release was measured and used as lipolytic index. RESULTS: Maximal lipolytic response per g triglycerides was about 50% lower in obese subjects both with and without a positive heredity and in non-obese subjects with a family trait for obesity as compared to non-obese subjects without such trait (P 0.0001). Fat cell volume was twice as high in obese as compared to lean subjects. Drug-induced maximal glycerol release per fat cell in the obese subjects, regardless of family history of obesity, reached a similar level, but did not exceed that of the lean group without heredity. CONCLUSIONS: Obesity is associated with catecholamine resistance with a relatively ineffective lipolysis in fat cells, and presence of a family history of obesity was not associated with a further suppression of lipolysis. In the lean subjects, heredity for obesity signi®cantly in¯uenced lipolysis to similar low levels as in the obese subjects.
Introduction
Obesity has become a major health problem worldwide and the prevalence is steadily increasing. 1,2 A mixture of psychosocial and environmental factors are responsible, 3 but increasing evidence of in¯uence of genetic factors has come forth through studies of twins and families with obesity. 4, 5 Due to this complex aetiology of obesity in man, less is known about the absolute genetic contribution. Since white fat mass is a target organ in obesity, it is tempting to speculate whether heredity one of the mechanisms responsible for the regulation of storage and mobilization of body fat mass could contribute to the overweight condition. The speci®c mechanisms that control these reactions in fat cell metabolism would therefore be of interest.
In man, lipids are mobilized from adipose tissue through lipolysis, a hormonally strictly regulated process where triglycerides are hydrolysed to the end products, free fatty acids and glycerol. Catecholamines are the main lipolytic hormones in man and stimulate lipolysis in adipocytes by binding to beta 1, 2 and 3-adrenoceptors, 6, 7 activating the lipolytic cascade, the last step being activation of the enzyme hormone-sensitive lipase. 8 There is evidence of several defects in lipolysis and fat cell metabolism in obesity. This includes resistance to catecholamine action in particular in upperbody obese subjects, as demonstrated in vitro 9 and also in vivo. 10 Less is known of whether these defects are of pathophysiological importance for the development of obesity or if they are a consequence of the overweight condition. Further, it is not known whether defects in adipocyte metabolism could be part of a genetic transmission that contributes to the aggregation of obesity seen in families.
Few studies in recent years have dealt with a possible genetic effect on adipocyte lipolysis, but there are some reports from family studies revealing signi®cant heritability levels for adrenaline stimulated lipolysis from abdominal adipocytes. 11, 12 In a recent study 13 we investigated possible hereditary or early onset defects in the regulation of catecholamineinduced lipolysis in fat cells in normal weight subjects with a family history of obesity. We found a resistance to catecholamine action in adipocytes with a signi®cantly lower maximum induced lipolysis in subjects that had obesity among their ®rst degree relatives as compared to those that lacked a family history of overweight. It is not known how lipolysis is regulated in obese subjects with or without a heredity for obesity.
The aim of the present study was to further evaluate the in¯uence of heredity for obesity on changes in adipocyte metabolism and if this could be associated with overweight. We investigated catecholamineinduced lipolysis in vitro in adipocytes obtained by abdominal, subcutaneous fat biopsies from a large number of obese and non-obese subjects that either had a positive family history of obesity or lacked obese members among their ®rst degree relatives.
Materials and methods
From an on-going prospective project characterizing adipocyte metabolism by a subcutaneous fat biopsy in lean and obese subjects, the possible family history of obesity among the participants was investigated by interviewing their ®rst-degree relatives about their current height and weight. By the criteria to include only subjects where complete data from nuclear family members was obtained, 127 subjects aged 19 ± 60 y (41 men and 86 women) could be included in this study. The body mass index (BMI) ranged from 17.8 to 60.2 kgam 2 and the waist-to-hip ratio ranged from 0.716 to 1.085. Obesity was de®ned as a BMI of 27 kgam 2 or more, since epidemiological studies have suggested that the mortality risk increases above this cut-off point, as discussed previously 14 By this de®ni-tion, 67 subjects were classi®ed as being non-obese (BMI range 17.8 ± 26.6 kgam 2 ) and the remaining 60 were obese (BMI range 27.2 ± 60.2 kgam 2 ), all otherwise healthy and drug-free.
Obesity occurred in the families of 50 of the 60 obese probands. In all except two of these families, one or both parents, alternatively one parent and one or several brothers and sisters, were obese and in 10 families all members were obese. In two families obesity was found only in brothers and sisters. Forty-two of the 67 lean subjects had at least one obese member among ®rst degree relatives, but generally obesity was not as prevalent in the families of these probands as compared with the corresponding obese; in none of these families did obesity occur in all members or in both parents. Twenty-®ve of the lean subjects had only non-obese family members.
All subjects had given their informed consent prior to entering the study. The study was approved by the ethics committee of the Karolinska Institute.
Experimental protocol
The subjects were investigated in the morning after an overnight fast. Height, body-weight and waist ± hip ratio were measured. They then rested in the supine position for 15 min, whereafter blood pressure was recorded and venous blood samples were obtained for the determination of glucose and lipids by the hospital's routine chemistry laboratory and of insulin by our own laboratory (using a commercial radioimmunoassay kit from Pharmacia Upjohn; Uppsala, Sweden). A subcutaneous fat biopsy (0.5 ± 2.5 g) was obtained under local anaesthesia from the abdominal region immediately to the right or the left of the umbilicus. The local anaesthesia was given so that it did not in¯uence the function of the removed adipose tissue. 15 
Isolation of fat cells and lipolysis experiments
Isolated fat cells were prepared by incubation in collagenase according to Rodbell. 16 The cells were then packed by centrifugation for 1 min at 600 rpm in a Beckman centrifuge. Fat cell diameter was calculated from the cell diameter measurements of 100 cells in each individual. Total lipid content in the incubate was measured by organic extraction. In this way, the mean cell weight and volume and further the number of fat cells in each incubate can be calculated as described previously 17 For performing the lipolysis assay, a diluted suspension of fat cells (about 5000 ± 10,000 cellsaml) was incubated in duplicate samples with air as the gas phase for 2 h at 37 C in Krebs ± Ringer phosphate buffer (pH 7.4) supplemented with glucose (1 mgaml), ascorbic acid (0.1 mgaml) and bovine serum albumin (20 mgaml) in the absence (basal) or presence of different lipolytic agents. These were isoprenaline (10 À9 ± 10 À5 molal), a non-selective beta-adrenoceptor agonist, forskolin (10 À7 ± 10 À4 molal), stimulating adenylyl cyclase and ®nally the phosphodiesteraseresistant cyclic AMP analogue dibutyryl cyclic AMP (10 À5 ± 10 À3 molal), which stimulates the protein kinase hormone-sensitive lipase complex. Increasing concentrations of each drug were used in order to identify the maximum effective concentration in adipocytes from each subject.
After incubation an aliquot of the medium was removed and glycerol, which was used as a measurement of the lipolysis rate, was analysed using a bioluminescence method. 18 Since fat cell size differed between the studied groups, the results were expressed using both triglyceride weight (g) and number of cells in the incubation medium as denominators.
Drugs and chemicals
Bovine scrum albumin (fraction V, lot 63F-0748), clostridium histolyticum collagenase type I, forskolin and dibutyryl cAMP were obtained from Sigma (St Louis, MO, USA). Isoprenaline came from Ha Èssle (Mo Èlndal, Sweden). ATP monitoring reagent containing ®re¯y luciferase was from LKB Wallac (Turku, Finland). All other chemicals were of the highest grade of purity commercially available. Collagenase and other ingredients in the incubation buffers were from the same batches throughout the study. Lipolysis 
Statistical analysis
Data are presented as meansAE standard error of the mean (s.e.). Data were compared using analysis of variance (ANOVA).
Results
Based on the BMI, the participants were classi®ed as being lean or obese and each of these groups in turn was subdivided according to whether obesity occurred in the family or not. The data on BMI of ®rst degree relatives were for practical reasons obtained from interviews. We have earlier demonstrated that this is a method with satisfactory accuracy. 13 Clinical data are presented in Table 1 . A majority, or 50 of the 60 obese subjects, had a positive family history of obesity while only 10 of the obese subjects had only normal weight ®rst degree relatives. Using analysis of variance (ANOVA), there was no difference between the two groups of lean subjects with or without heredity for obesity as regards all parameters listed in Table 1 . With some reservation for the small number of obese subjects without heredity there were likewise no differences in this respect between the two groups of obese subjects. All groups were comparable as regards age. The obese subjects generally had signi®cantly higher levels of plasma insulin and blood glucose and lower HDL-cholesterol as well as higher blood pressure as compared to the lean subjects, and they further had almost twice as large fat cells (P`0.005 or less by ANOVA).
As regards lipolysis data, basal lipolysis rate (ie without lipolytic agents present in the incubation medium) was signi®cantly higher in obese as compared to lean subjects. The values, presented as mmol glycerolag triglycerides were in lean subjects 0.81 (with heredity), 1.1 (without heredity) and 1.3 for obese subjects with as well as without heredity for obesity (P`0.005 using ANOVA). There was no signi®cant difference in basal lipolysis between the two groups of lean subjects. As seen in Table 1 , fat cell weight was almost twice as high in obese as in lean subjects and expressed per cell, basal lipolysis was about 50% higher in the obese subjects. A family history of obesity did not in¯uence fat cell weight in the obese or lean group respectively.
Maximum stimulated lipolysis data expressed as glycerol releaseag triglycerides are shown in Figure  1 . Regarding the lean subjects, the catecholamineinduced rate of lipolysis was about 40% higher in those without heredity for obesity than in those with a positive family history and this was also true when lipolysis was stimulated with isoprenaline or at postreceptor levels with forskolin and dibutyryl cyclic AMP (P 0.006 or less). Since the fat cell weight did not differ between these subgroups of lean subjects, the difference in lipolysis rate was of the same magnitude when data were expressed per cell ( Figure  2 ). These ®ndings in non-obese subjects are in accordance with our earlier study. 13 There was no difference in lipolysis rate among obese subjects with or without heredity for obesity regardless of whether the values were expressed per g triglycerides or per cell (Figures 1 and 2) .
When maximum lipolysis rate was compared in lean and obese subjects, glycerol levels were about 50% lower in obese individuals as compared to those in lean subjects without heredity when expressed per g triglycerides (Figure 1 ). This was true for lipolysis stimulated both at the receptor and at the postreceptor level. On the other hand, lipolysis rate did not differ between the obese group and those lean subjects that had a family history of obesity, with a minor exception in isoprenaline-induced lipolysis where obese subjects with heredity had a slightly but signi®cantly lower lipolysis as compared to lean subjects with heredity.
If, instead, glycerol release was expressed per cell ( Figure 2 ) and compared in lean and obese subjects, the latter group had signi®cantly higher maximum induced lipolysis by about 40% as compared to lean Values are mean AE s.e. Data was compared using analysis of variance (ANOVA). Pos her positive heredity for obesity, neg her negative heredity for obesity, SBP systolic blood pressure, DBP diastolic blood pressure.
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Discussion
In this study, we have investigated the possible in¯uence of a family history of obesity on fat cell metabolism in obese and non-obese subjects with or without heredity for obesity. The data suggest that the lipolytic action of drugs acting on the beta-adrenoceptor, as well as on the post-receptor level, is impaired and relatively inef®cient both in lean subjects with obese ®rst degree relatives and in obese subjects regardless of whether a family history of obesity was present or not, and more ef®cient in lean subjects that lacked heredity for obesity.
The results in lean subjects demonstrated an approximately 50% higher drug-induced maximum glycerol release in non-obese individuals without a family trait for obesity as compared to those with obesity among ®rst degree relatives. Thus, we have so far con®rmed the results of our previous study in this new and larger cohort. 13 We here found no differences in plasma insulin, blood lipids or other clinical parameters between the two non-obese subgroups.
Obesity was generally associated with a suppressed lipolysis as compared to lean subjects when glycerol release was expressed per g of triglycerides. Of note Lipolysis and heredity for obesity L Hellstro Èm and S Reynisdottir was the fact that when data were expressed per fat cell we found that despite twice as large fat cells, obese subjects achieved only 40% higher maximum glycerol values than did non-obese subjects with a family trait for obesity and the level did not exceed that of the lean subjects that lacked a heredity for obesity. This indicates a less ef®cient lipolytic activity per fat cell in obese subjects.
When lipolysis data were compared between the groups of obese subjects with or without heredity for obesity, the statistical calculations showed no differences in maximum induced glycerol release, neither when lipolysis was stimulated at the overall beta-adrenoceptor level with isoprenaline, of at post-receptor levels with forskolin or dibutyryl cyclic AMP. A majority of the obese participants in the study had obese ®rst degree relatives. Thus, only 10 of the 60 obese participants recruited lacked a family history of obesity completely. This ®nding was not surprising since it is well known that obese parents are more likely to have obese children than are lean parents. 19, 20 This fact, however, contributes to dif®culties in studying this speci®c group of obese subjects with only non-obese family members. Since this latter group was small, data must be interpreted with care, especially as regards conclusions about the possible in¯uence of heredity for obesity on lipolysis in the obese group and since besides a possible genetic in¯uence a large number of factors can have an effect on lipolysis in man.
Lipolysis data taken together indicate that a defect in lipolysis in non-obese subjects with a family history of obesity and in obese subjects resides in the lipolytic chain near the level of the hormone-sensitive lipase. A decreased activity of this enzyme was earlier demonstrated in another smaller cohort of lean subjects with a positive heredity for obesity. 13 Unfortunately, not enough fat tissue could be obtained from a suf®cient number of subjects to allow a further analysis of the mechanism involved in this lipolytic defect, including measurement of the hormone-sensitive lipase.
A cautious speculation when looking upon the data altogether would be that a hereditary trait for obesity contributes to suppression of lipolysis in fat cells in lean subjects, while when a subject already has become obese the presence of a genetic predisposition for obesity plays a minor role for lipolysis. In this latter situation, other factors might be of greater importance, such as higher plasma insulin concentrations, which can lower lipolysis in human fat cells by downregulation of beta-adrenoceptors. 21 In summary, this study has provided evidence for a lipolysis defect in obese subjects with a relatively inef®cient glycerol release per fat cell regardless of whether a family history of obesity was present or not. In lean subjects, heredity for obesity signi®cantly reduced lipolysis to similar low levels as in the obese subjects. What impact these defects in lipolysis regulation might have for the development of obesity and what importance the genetic contribution may have can only be answered by long-term prospective studies.
